# Optimizing Surgical Conditions During Laparoscopic Herniotomy With Deep Neuromuscular Blockade

> **NCT02247466** · PHASE4 · COMPLETED · sponsor: **Herlev Hospital** · enrollment: 37 (actual)

## Conditions studied

- Laparoscopic Herniotomy

## Interventions

- **DRUG:** Rocuronium and Sugammadex

## Key facts

- **NCT ID:** NCT02247466
- **Lead sponsor:** Herlev Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2017-02-23
- **Final completion:** 2017-02-23
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2019-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02247466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02247466, "Optimizing Surgical Conditions During Laparoscopic Herniotomy With Deep Neuromuscular Blockade". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02247466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*